Kromek Share Discussion Threads

[aqc888] 09/1/2022 20:37

Wonder how profitable Kromek would be if they halted all research and development? Not that that’s what I’d want.

Got to remember it’s a choice to keep spending on new IP such as the biological pathogen detector. It’s easy to complain about Kromek and it’s constant losses while they are spending all this money on IP. But I bet the moment they strike gold with a bit of IP such as the biological pathogen detector or the low dose CZT breast cancer scanners, this spending will be viewed very differently.

Kromek need to make better sales with old intellectual property they’ve developed, for investors to be comfortable with all the new spending. Hopefully we’ll find we’ve reached that point at the interim results.

Big lag time between the spending and the rewards. But hopefully we’ll find out the tide has finally turned at the interims.

[strategicinvestor2] 09/1/2022 20:10

Key from the interims is core business performance as some have said. Pathogen detector commercialisation coinciding with interims unlikely but hopefully strong progress update. If core revenue targets being met or exceeded could inspire a lot of confidence ahead of further developments. IHMO DYOR

[strategicinvestor2] 09/1/2022 16:25

I see the base medical and threat detectors justifying a 50 - 80p valuation which will only rise with the rapid growth in demand forecast in these markets. Pathogen detection on top could add £s to this … IMHO DYOR

[33mick] 09/1/2022 12:57

The history of how Kromek and it's tech and IP to date is the history..warts and all, but most invested here now are here for the very bright and rosey future Kromek's hard work and world beating tech could produce...with not any obvious competition I can see or am aware of.

The US wants a Kromek type full on RNA/DNA networked low cost low maintenance system. They've not changed Thier minds nor are likely too. The world's now a bit more of a dangerous place. Than when tI was just Anthrax to worry about.

Sep 16, 2021
Desired Capabilities:

"The DHS CWMD office intends to deploy biosensors in both indoor and outdoor urban environments to conduct real-time monitoring of biological threats and seeks industry to continue research and development efforts in order to meet characterization and cost goals. The redesign of the commercially available biosensors is being proposed to occur over 15 months and will take place in 2 phases, to include: the design of at least 2 prototypes that will be tested by the performer followed by an opportunity for a prototype redesign before delivering the final prototypes to the government for an independent operational background test and chamber test."

[aqc888] 09/1/2022 07:07

Very disappointing history. The disappointment could continue. You’ve got to weigh the poor history of commercialisation with the strong history of product development. Hopefully the new chairman will assist here. But clearly the CEO was out of his depth on the commercial side. Very low entry point now. Could so easily rise to beyond £2 if a few governments buy the detection system. I suspect Jan 18th will have results a little better than expected and more ‘promising news’, but no orders, on the detector. But this should be enough to see the share price rise on 18th and should be enough to get it included in ST bargain shares edition. That’s the most likely scenario for the next 4weeks

[ark87] 08/1/2022 22:40

Apparently commercial deployment was a possibility in 2021, would be nice to know why it didn't happen??

Wed, 13th Jan 2021

"Kromek is engaging with potential customers for the COVID-19 detection system...
The Group expects the first pilots with potential users to commence by the end of this financial year and anticipates commercial deployment in 2021/22"

[pottytastic] 08/1/2022 21:28

Why are you here?

[quepassa] 08/1/2022 19:38

YAWN YAWN YAWN

AQC- "I'M JUST WAITING FOR THE CHANCE TO EXIT".

[aqc888] 08/1/2022 15:30

Quepassa, a pathetic and sad loser. You can quote me on that in four months too.

[quepassa] 08/1/2022 10:51

YAWN YAWN YAWN


NOTA BENE his words:- "I'M JUST WAITING FOR THE CHANCE TO EXIT".

[aqc888] 08/1/2022 10:28

Sentiment has clearly changed quite dramatically with Kromek looking at the share price over the last 2years, including my sentiment. My last post over on LSE points out the many conflicting views of Kromek that are interesting to navigate through. In fact I just said that gains were frothy and hard not to sell when the share price booms over on lse.

The only thing that doesn’t change is Quepassas refusal to state his interest in Kromek and his DELIBERATE attempts to cause panic as seen in other posts of his (won’t repeat his nonsense that was disproved comprehensively by multiple other posters).

I think people can judge for themselves who can and can’t be trusted. I’ve openly discussed my frustrations with Kromek and had my views change over time. Quepassa has a very unusual position on Kromek, he puts in a lot of time and effort trying to discredit a company he apparently has no interest in. I’ve built up a large holding in Kromek, that’s my interest here. What’s your interest QP? You spend a lot of your time going through company accounts, old posts etc trying to find things to ‘warn’ others about, warning how the share price is about to tank and dire etc etc. Is this a public service/charity you’re operating? Or would you like to enlighten us to your noble views? I suspect I know your predictable answer - yawn yawn yawn.

[strategicinvestor2] 08/1/2022 10:13

My sentiment and frustration has changed several times - end up on deeper analysis I conclude definitely not a share I want to be out of. GLA

[quepassa] 08/1/2022 09:25

Treat everything you read from AQ with extreme caution. He will do anything to ramp his position in an attempt to sucker in other investors.

This is what AQ wrote on 24/9/21 in his post 5235:

"Kromek have such little credibility that even if one of their biological detectors work I’m just waiting for the chance to exit. I’m still in profit with my Kromek holding having bought my first batch at 11p and my most recent batch at 17.4p but I just don’t like this nonsense - either tell us everything or nothing about the biological pathogen detectors. This teasing with information constantly has eroded my trust completely."


NOTA BENE his words:- "I'M JUST WAITING FOR THE CHANCE TO EXIT".



ALL IMO. DYOR.
QP

[aqc888] 08/1/2022 07:43

Simon Thompson clearly believes in Kromek and has been persuaded of its potential giving it his repeated ‘strong buys’ - which are fairly rare.

2022 is the year sales of the biological pathogen detector will happen, if they happen at all. Kromek is also at share price lows with the main business performing the best in years.

That sounds like the recipe for Kromek to be included in his 2022 bargain shares edition. Which will give it a 20-40% boost early feb.

If we hear at the interim results that the main business is not loss making and has turned the corner. Plus the potential of the biological pathogen detector on top. That’s a safe tip which won’t risk ruining his bargain portfolio record, with a lot of upside.

[techno20] 08/1/2022 04:58

Pleasing to see 12 vacancies currently being recruited. Half UK, half US. Suggests a level of confidence across the board. Couple in the bio-med area. Keeping the faith for a while longer - been on board for 8 years so far. Hopefully will be worth waiting another one!

[ark87] 07/1/2022 23:32

Acq - I think scenario 3 is most likely. Vague should be Basu’s middle name. I put it at about 75% . Based off previous history I’m giving “scenario 1” a 2% chance. Prove me wrong Basu!!

[b00mb0y] 07/1/2022 19:48

Reading a few blogs on the LSE board, it seems to me that the ramping blogs are saying that the lack of news is down to confidentiality. Hmmmm…… I hope so!

[estienne] 07/1/2022 09:20

You really have to be careful of hi-tech stocks like Kromek. I've seen so many founder along like this for years and never produce the returns investors hoped for.

[aqc888] 06/1/2022 17:53

So boomboy, you claim to be heavily invested in Kromek yet keep talking about how it’s value is about to collapse? Don’t really understand.

Kromeks price is volatile as usual. No new news. All speculation till 18th Jan interim results. Who really cares about the ups and downs till then, since the ups and downs will all be erased by the news or otherwise of the biological pathogen detector and wider results on 18th Jan

[b00mb0y] 06/1/2022 17:06

This could be the next slide down towards .04p. I hope not.

[b00mb0y] 06/1/2022 15:18

One step forward two steps back. Don’t get excited, gamblers.

[strategicinvestor2] 05/1/2022 12:51

Excellent points ACQ - well made…